Malignant Neoplasm of Stomach Recruiting Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03760822Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer PatientsTreatment
NCT03283761FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction AdenocarcinomaTreatment
NCT03263741Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerTreatment
NCT02501603Afatinib, Paclitaxel, 2nd Line, Advanced Gastric CancerTreatment
NCT02931890Multicentric Randomised Trial for Resectable Gastric CancerTreatment
NCT01522768Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric CancerTreatment
NCT03083613Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaTreatment
NCT01739894Feasibility Study of Intraperitoneal PaclitaxelTreatment
NCT02529878Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric CancerTreatment